Andre Delacourte
Inventor
Stats
- 3 US patents issued
- 7 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 3 US Patents Issued
- 7 US Applications Filed
- 124 Total Citation Count
- Dec 16, 2010 Most Recent Filing
- Nov 5, 2001 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| UNIVERSITE LILLE 1-SCIENCES ET TECHNOLOGIES | 2
| 2010
|
| CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE | 2
| 2010
|
| Innogenetics N.V. | 2
| 2008
|
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) | 1
1 2 2 2 | 2001
2003 2005 2008 2010 |
| UNIVERSITE DU DROIT ET DE LA SANTA-LILLE II | 1
| 2005
|
| UNIVERSITE LILLE 2 DROIT ET SANTE | 2
| 2010
|
| SANOFI | 2
| 2008
|
| Universite Lille 1—Sciences et Technologies | 1
| 2010
|
| UNIVERSITE DU DROIT ET DE LA SANTE-LILLE II | 2
| 2005
|
Inventor Addresses
| Address | Duration |
|---|---|
| Faches Thumesnil, FR | Aug 11, 05 - Jan 01, 13 |
| Faches-Thumesnil, FR | Jul 27, 06 - Jun 02, 15 |
| Faches-thumesnil, FR | Jun 11, 09 - Jun 11, 09 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
| C07D: | HETEROCYCLIC COMPOUNDS | 2 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 9044478 | 2015 | Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases | 0 |
| 8680095 | 2014 | Heterocycle compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the APP metabolism occurs | 0 |
| 8343493 | 2013 | Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs | 2 |
| 2012/0283,256 | 2012 | NEW HETEROCYCLE COMPOUNDS AND USES THEREOF FOR THE PREVENTION OR TREATMENT OF DISEASES INVOLVING FORMATION OF AMYLOID PLAQUES AND/OR WHERE A DYSFUNCTION OF THE APP METABOLISM OCCURS | 0 |
| 2011/0059,092 | 2011 | ANTIBODIES SPECIFIC OF THE BETA-AMYLOID PEPTIDES AND THEIR USES AS DIAGNOSTIC AGENTS OR DRUGS | 12 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.